Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.98

Bid

0.98

Ask

0.99

Volume

2,009

0.00 Day's Range 0.00

0.67 52 Week Range 80.96

Market Cap

544.133k

Previous Close

1.025

Open

Last Trade

100

0.98

(formt)

Last Trade Time

05:48:07

Financial Volume

VWAP

Average Volume (3m)

1,063,954

Shares Outstanding

533,464

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-32.64

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $1.03. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.67 to $ 80.96.

Aptevo Therapeutics currently has 533,464 shares outstanding. The market capitalization of Aptevo Therapeutics is $544,133 . Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.03.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.16	-14.0350877193	1.14	1.38	0.9611	5942554	1.11924972	CS
4	0.0094	0.968473109417	0.9706	1.38	0.67	2262399	1.04153614	CS
12	-5.554	-85.0015304561	6.534	10.8	0.67	1063954	2.32243648	CS
26	-9.2808	-90.4490877904	10.2608	10.8988	0.67	711016	3.95486827	CS
52	-73.38	-98.6820871436	74.36	80.96	0.67	524880	11.05294762	CS
156	-1041.82	-99.9060222478	1042.8	1397.44	0.67	577917	393.65735728	CS
260	-35.54	-97.3165388828	36.52	2640	0.67	579736	410.62962131	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CPOPPop Culture Group Company Ltd	$ 2.55 (50.00%)	743.21k
SEZLSezzle Inc	$ 61.00 (36.34%)	7.22k
IVPInspire Veterinary Partners Inc	$ 4.76 (31.13%)	903.44k
MOVEMovano Inc	$ 0.4998 (24.95%)	116
SYPRSypris Solutions Inc	$ 1.60 (22.14%)	258
CTMXCytomX Therapeutics Inc	$ 2.59 (-38.19%)	1.04M
TIVCTivic Health Systems Inc	$ 0.8451 (-36.93%)	352.47k
EMKREMCORE Corporation	$ 1.98 (-31.72%)	1.5k
CDLXCardlytics Inc	$ 10.40 (-28.77%)	6.1k
ONVOOrganovo Holdings Inc	$ 0.7205 (-24.95%)	28.76k
CTMXCytomX Therapeutics Inc	$ 2.59 (-38.19%)	1.04M
IVPInspire Veterinary Partners Inc	$ 4.76 (31.13%)	903.44k
AIXIXIAO I Corporation	$ 1.40 (11.11%)	869.56k
CPOPPop Culture Group Company Ltd	$ 2.55 (50.00%)	743.21k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0424 (1.44%)	737.28k